Apart from PD-L1, there are currently several additional biomarkers that are being investigated for their potential role in tumor differentiation, proliferation, or aggressiveness in lung cancer and could in the future be integrated into the daily routine as prognostic and/or predictive biomarkers [33]. This evidence concerns the gene CD274 and lung carcinoma.